- Home
- ADMA vs DNP Comparison
ADMA vs DNP Comparison
Compare ADMA & DNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADMA
- DNP
- Stock Information
- Founded
- ADMA 2004
- DNP 1986
- Country
- ADMA United States
- DNP United States
- Employees
- ADMA N/A
- DNP N/A
- Industry
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- DNP Investment Managers
- Sector
- ADMA Health Care
- DNP Finance
- Exchange
- ADMA Nasdaq
- DNP Nasdaq
- Market Cap
- ADMA 4.1B
- DNP 3.4B
- IPO Year
- ADMA N/A
- DNP N/A
- Fundamental
- Price
- ADMA $17.89
- DNP $8.98
- Analyst Decision
- ADMA Strong Buy
- DNP
- Analyst Count
- ADMA 4
- DNP 0
- Target Price
- ADMA $21.25
- DNP N/A
- AVG Volume (30 Days)
- ADMA 2.6M
- DNP 708.8K
- Earning Date
- ADMA 02-26-2025
- DNP 01-01-0001
- Dividend Yield
- ADMA N/A
- DNP 8.63%
- EPS Growth
- ADMA N/A
- DNP N/A
- EPS
- ADMA 0.28
- DNP N/A
- Revenue
- ADMA $382,809,000.00
- DNP N/A
- Revenue This Year
- ADMA $66.84
- DNP N/A
- Revenue Next Year
- ADMA $14.72
- DNP N/A
- P/E Ratio
- ADMA $63.82
- DNP N/A
- Revenue Growth
- ADMA 63.39
- DNP N/A
- 52 Week Low
- ADMA $4.37
- DNP $8.09
- 52 Week High
- ADMA $23.64
- DNP $11.18
- Technical
- Relative Strength Index (RSI)
- ADMA 42.39
- DNP 36.20
- Support Level
- ADMA $17.08
- DNP $8.75
- Resistance Level
- ADMA $18.97
- DNP $9.06
- Average True Range (ATR)
- ADMA 0.75
- DNP 0.16
- MACD
- ADMA -0.20
- DNP -0.03
- Stochastic Oscillator
- ADMA 27.81
- DNP 27.32
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
About DNP DNP Select Income Fund Inc.
DNP Select Income Fund Inc is a closed-ended investment management fund. The primary investment objectives of the fund are current income and long-term growth of income. Its secondary objective is capital appreciation. The Fund seeks to achieve its investment objectives by investing in the public utility industry.